Vergoeding 2019-2023 voor ATC-subgroep S01EE : Prostaglandine-analoga
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| S01EE01 Latanoprost (Monoprost ®) | 3.711.000 | 3.949.300 | 3.785.800 | 4.087.000 | 4.472.200 |
| S01EE03 Bimatoprost (Lumigan ®) | 2.295.900 | 2.171.500 | 1.976.100 | 2.078.500 | 2.163.000 |
| S01EE04 Travoprost (Travatan ®) | 1.594.900 | 1.305.400 | 1.136.100 | 1.117.400 | 1.037.600 |
| S01EE05 Tafluprost (Saflutan ®) | 1.890.200 | 1.780.000 | 1.558.500 | 1.602.100 | 1.584.600 |
| Totaal | 9.492.000 | 9.206.200 | 8.456.500 | 8.885.000 | 9.257.400 |